I think the good news here is that there is already a lot in place. We spoke about the Canadian integrated program for antimicrobial resistance surveillance, which is a surveillance program out of the Public Health Agency of Canada that has been in place for over a decade. It started out just looking at resistance levels, but they are also looking at on-farm use levels of antibiotics. There has been a lot developed there. A relationship has been built in terms of how this surveillance can be done and how the data can be analyzed. I think that has been an important vehicle for both industry and government to understand from a credible data source.
From our perspective, we would like to see that expanded. It is in a small number of sites. We are looking at the need to increase the amount of surveillance that's done, especially as we move through the pan-Canadian framework, and really try to understand some of the resistance trends that we see out there and why we see differences in some provinces and regions. That's an integral part of the strategy moving forward, and we need to continue that support for surveillance.